Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.8K Sell
48
-100
-68% -$47.2K 0.01% 284
2025
Q4
$63.1K Hold
148
0.03% 193
2025
Q3
$70.3K Hold
148
0.02% 178
2025
Q2
$69.4K Buy
148
+100
+208% +$45.6K 0.04% 172
2025
Q1
$22.4K Hold
48
0.01% 188
2024
Q4
$20.1K Hold
48
0.01% 200
2024
Q3
$22.9K Hold
48
0.01% 196
2024
Q2
$21.1K Hold
48
0.01% 194
2024
Q1
$22.3K Hold
48
0.02% 189
2023
Q4
$19.7K Hold
48
0.01% 188
2023
Q3
$17.9K Hold
48
0.02% 189
2023
Q2
$18.3K Hold
48
0.02% 186
2023
Q1
$17.1K Sell
48
-319
-87% -$107K 0.01% 175
2022
Q4
$120K Sell
367
-33
-8% -$10.3K 0.1% 123
2022
Q3
$108K Buy
400
+204
+104% +$58.6K 0.1% 111
2022
Q2
$56K Hold
196
0.04% 170
2022
Q1
$63K Buy
196
+148
+308% +$45.8K 0.04% 177
2021
Q4
$17K Sell
48
-140
-74% -$45.4K 0.01% 287
2021
Q3
$55K Buy
188
+48
+34% +$14.6K 0.03% 222
2021
Q2
$40K Sell
140
-66
-32% -$19.2K 0.05% 235
2021
Q1
$58K Buy
+206
New +$53.4K 0.08% 195
2020
Q2
Sell
-21
Closed -$4K 273
2020
Q1
$4K Sell
21
-108
-84% -$21.3K 0.02% 217
2019
Q4
$27K Buy
+129
New +$26K 0.05% 160

Other funds holding LIN

Solstein Capital's LIN Position: Q1 2026 in Review

Solstein Capital reduced its Linde (LIN) stake by 68% in Q1 2026, selling an estimated $47.2K and leaving 48 shares worth $23.8K. The position accounts for 0.01% of the portfolio, ranked #284.

Solstein Capital first reported a position in LIN in Q4 2019 and has held it in 23 quarters since. The position peaked at $120K in Q4 2022. 2,267 funds tracked by Wall St. Rank hold LIN as of Q1 2026.

  • Solstein Capital held 48 shares of Linde worth $23.8K as of Q1 2026.
  • Solstein Capital sold 100 Linde shares in Q1 2026, an estimated $47.2K.
  • Linde made up 0.01% of Solstein Capital's portfolio in Q1 2026, its #284 holding.
  • Solstein Capital first reported a position in Linde in Q4 2019 and has held it in 23 quarters since.
  • Solstein Capital's Linde position peaked at $120K in Q4 2022.
  • 2,267 funds tracked by Wall St. Rank held Linde as of Q1 2026.

Based on Solstein Capital's 13F filing for Q1 2026, filed 14 May 2026.